Maillard Reaction Crosslinked Alginate-Albumin Scaffolds for Enhanced Fenofibrate Delivery to the Retina: A Promising Strategy to Treat RPE-Related Dysfunction.

Abedin Zadeh M, Alany RG, Satarian L, Shavandi A, Abdullah Almousa M, Brocchini S, Khoder M

Open source

DOI
10.3390/pharmaceutics15051330
Published
2023 Apr 24
Container
Pharmaceutics
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/pharmaceutics15051330,
  title = {Maillard Reaction Crosslinked Alginate-Albumin Scaffolds for Enhanced Fenofibrate Delivery to the Retina: A Promising Strategy to Treat RPE-Related Dysfunction.},
  author = {Abedin Zadeh M and Alany RG and Satarian L and Shavandi A and Abdullah Almousa M and Brocchini S and Khoder M},
  year = {2023},
  journal = {Pharmaceutics},
  doi = {10.3390/pharmaceutics15051330},
  url = {https://doi.org/10.3390/pharmaceutics15051330}
}

RIS

TY  - JOUR
TI  - Maillard Reaction Crosslinked Alginate-Albumin Scaffolds for Enhanced Fenofibrate Delivery to the Retina: A Promising Strategy to Treat RPE-Related Dysfunction.
AU  - Abedin Zadeh M
AU  - Alany RG
AU  - Satarian L
AU  - Shavandi A
AU  - Abdullah Almousa M
AU  - Brocchini S
AU  - Khoder M
PY  - 2023
JO  - Pharmaceutics
DO  - 10.3390/pharmaceutics15051330
UR  - https://doi.org/10.3390/pharmaceutics15051330
ER  - 

APA

M, A. Z., RG, A., L, S., A, S., M, A. A., S, B., & M, K. (2023). Maillard Reaction Crosslinked Alginate-Albumin Scaffolds for Enhanced Fenofibrate Delivery to the Retina: A Promising Strategy to Treat RPE-Related Dysfunction.. Pharmaceutics. https://doi.org/10.3390/pharmaceutics15051330

Source records